Travere Therapeutics, Inc.TVTXNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank86
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-0.60
↑ 77% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-2.59
Historical baseline
PeriodValueYoY Change
TTM-0.60+85.3%
2024-4.08-172.0%
2023-1.50+65.7%
2022-4.37-45.2%
2021-3.01+15.4%
2020-3.56-2.9%
2019-3.46-36.2%
2018-2.54-64.9%
2017-1.54-23.2%
2016-1.25-